Document -
The National Institute for Health and Care Excellence (NICE) Issues Positive Guidance for AbbVie’s MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Adults with All Major Genotypes (GT1-6) of Chronic Hepatitis C in England and Wales
go to media item
- License:
- All rights reserved
The Content may only be used by Mynewsdesk. It is thus not permissible for anyone else to download, copy, distribute or otherwise use the Content (other than for private use to the extent permitted by law).
- File format: